AUGMENTATION OF THE THERAPEUTIC EFFICACY OF ADOPTIVE TUMOR-IMMUNOTHERAPY BY INVIVO ADMINISTRATION OF SLOWLY RELEASED RECOMBINANT INTERLEUKIN-2

被引：4

作者：

NISHIMURA, T

TOGASHI, Y

GOTO, M

YAGI, H

UCHIYAMA, Y

HASHIMOTO, Y

机构：

来源：

CANCER IMMUNOLOGY IMMUNOTHERAPY | 1986年 / 21卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：12 / 18

页数：7

共 45 条

[1]

BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69

[2] STUDIES ON CHEMICALLY-INDUCED RAT-TUMORS .2. PARTIAL PROTECTION AGAINST SYNGENEIC LETHAL TUMORS BY CLONED SYNGENEIC CYTO-TOXIC LYMPHOCYTES-T [J].

BINZ, H ;

FENNER, M ;

ENGEL, R ;

WIGZELL, H .

INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (04) :491-500

[3] INHIBITION OF ESTABLISHED TRANSPLANTS OF CHEMICALLY INDUCED SARCOMAS IN SYNGENEIC MICE BY LYMPHOCYTES FROM IMMUNIZED DONORS [J].

BORBERG, H ;

BEATTIE, EJ ;

CHOUDRY, K ;

OETTGEN, HF .

INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (03) :539-&

[4] INTERLEUKIN 2 (IL-2) ACTIVITY DURING TUMOR-GROWTH - IL-2 PRODUCTION KINETICS, ABSORPTION OF AND RESPONSES TO EXOGENOUS IL-2 [J].

BURGER, CJ ;

ELGERT, KD ;

FARRAR, WL .

CELLULAR IMMUNOLOGY, 1984, 84 (02) :228-239

[5]

Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9

[6] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].

CHEEVER, MA ;

GREENBERG, PD ;

FEFER, A ;

GILLIS, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980

[7]

CHEEVER MA, 1984, J IMMUNOL, V132, P2259

[8]

CHIBA K, 1985, J IMMUNOL, V134, P3172

[9]

CHIBA K, 1985, J IMMUNOL, V134, P1026

[10]

CHIBA K, 1985, J IMMUNOL, V134, P1019

← 1 2 3 4 5 →